中基健康
(000972)
| 流通市值：27.84亿 | | | 总市值：27.84亿 |
| 流通股本：7.71亿 | | | 总股本：7.71亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 287,695,442.16 | 196,809,756.29 | 54,821,851.96 | 492,115,607.53 |
| 营业总成本 | 390,865,012.73 | 267,349,675.09 | 76,544,878.06 | 675,945,880.11 |
| 其他经营收益 | | | | |
| 营业利润 | -123,698,067.4 | -69,324,860.44 | -20,079,930.94 | -48,779,313.71 |
| 利润总额 | -123,976,148.12 | -69,513,916.66 | -20,266,150.6 | -51,770,910.16 |
| 净利润 | -124,040,986.03 | -68,191,633.75 | -20,374,945.59 | -56,032,745.96 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | -277,831.54 |
| 综合收益总额 | -124,040,986.03 | -68,191,633.75 | -20,374,945.59 | -56,310,577.5 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 609,765,333.64 | 552,650,249.85 | 709,043,794.82 | 768,531,386.69 |
| 非流动资产: | | | | |
| 非流动资产合计 | 448,465,774.56 | 443,586,277.95 | 452,699,988.56 | 453,449,656.59 |
| 资产总计 | 1,058,231,108.2 | 996,236,527.8 | 1,161,743,783.38 | 1,221,981,043.28 |
| 流动负债: | | | | |
| 流动负债合计 | 981,712,318.14 | 864,457,098.18 | 978,850,906.51 | 1,017,526,005.81 |
| 非流动负债: | | | | |
| 非流动负债合计 | 173,557,539.64 | 172,968,826.92 | 176,265,586.01 | 177,452,801.02 |
| 负债合计 | 1,155,269,857.78 | 1,037,425,925.1 | 1,155,116,492.52 | 1,194,978,806.83 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | -93,674,796.43 | -39,796,742.42 | 6,492,780.51 | 26,122,298.88 |
| 股东权益合计 | -97,038,749.58 | -41,189,397.3 | 6,627,290.86 | 27,002,236.45 |
| 负债和股东权益合计 | 1,058,231,108.2 | 996,236,527.8 | 1,161,743,783.38 | 1,221,981,043.28 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 330,172,417.14 | 216,397,748.6 | 55,273,315.17 | 665,188,171.84 |
| 经营活动现金流出小计 | 192,590,077.13 | 89,469,879.03 | 58,195,709.96 | 418,498,917.6 |
| 经营活动产生的现金流量净额 | 137,582,340.01 | 126,927,869.57 | -2,922,394.79 | 246,689,254.24 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 434,866.2 | 432,866.2 | - | 6,708,409.61 |
| 投资活动现金流出小计 | 17,685,919.32 | 10,671,732.08 | 6,506,860.27 | 57,048,996.89 |
| 投资活动产生的现金流量净额 | -17,251,053.12 | -10,238,865.88 | -6,506,860.27 | -50,340,587.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 9,235,093.06 | 8,564,100 | - | 219,080,000 |
| 筹资活动现金流出小计 | 192,968,023.65 | 137,289,165.24 | 21,473,217.1 | 267,315,968.47 |
| 筹资活动产生的现金流量净额 | -183,732,930.59 | -128,725,065.24 | -21,473,217.1 | -48,235,968.47 |
| 汇率变动对现金及现金等价物的影响 | -0.95 | -0.72 | -0.38 | 1.38 |
| 现金及现金等价物净增加额 | -63,401,644.65 | -12,036,062.27 | -30,902,472.54 | 148,112,699.87 |
| 期末现金及现金等价物余额 | 234,391,456.3 | 285,757,038.68 | 266,890,628.41 | 297,793,100.95 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -12,036,062.27 | - | 148,112,699.87 |